Inhibitors of α,-glucosidase and Angiotensin-converting Enzyme in the Treatment of Type 2 Diabetes and its Complications: A Review on in Silico Approach (Review Article)

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Kehinde Oyedele Abdul Quddus; Damilare Boyenle Ibrahim; OGUNLANA ABDEEN TUNDE; Ayoola Ashiru Mojeed; Emmanuel Atanda Opeyemi; Isaac Adelusi Temitope

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: PHARMACEUTICAL AND BIOMEDICAL RESEARCH Year:2022 | Volume:8 | Issue:4 Page(s): 237-258

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Inhibitors of α,-glucosidase and Angiotensin-converting Enzyme in the Treatment of Type 2 Diabetes and its Complications: A Review on in Silico Approach (Review Article)

Author(s)

Keywords

-glucosidase

Angiotensin-converting enzyme

In silico drug discovery

Pharmacological activity

ADMET

Abstract

Background: The use of pharmacological agents to synergistically target key enzymes associated with carbohydrate digestion (α,-glucosidase) and the hypertension-related angiotensin-converting enzyme (ACE) are critical strategies for the management of type 2 diabetes (T2D) and its end-stage complications. Furthermore, aside from their blood pressure-lowering effect, ACE inhibitors (ACEIs) are important therapeutic agents for preventing diabetic complications, highlighting their synergistic renoprotective and antihypertensive effects in diabetic patients who are normotensive and hypertensive. Objectives: We reviewed the safety and potent activity of phytochemicals discovered based on molecular docking and dynamics in recent years that could be used to treat T2D. Methods: We surveyed recently in silico drug discovery findings on α,-glucosidase and ACE retrieved from the PubMed database. Computational in silico ADMET meta-analysis was performed on 57 compounds that could potentially inhibit α,-glucosidase or ACE. Results: The review highlighted the fact that most hit compounds of α,-glucosidase and ACE involving the use of molecular docking and molecular dynamics techniques are competitive and peptide inhibitors, respectively. Moreover, we found that most authors do not consider absorption distribution metabolism excretion toxicity (ADMET) studies on drug candidates, which is important in determining the safety profile of potent leads. Hence, we performed in silico ADMET meta-analysis of the reported compounds and found some inhibitors with an excellent pharmacological profile. Conclusion: We propose that further studies be conducted on these promising leads to demonstrate their efficacy and safety in the treatment of T2D.

Multimedia

No record.

Cites

No record.

References

Cite

APA: Copy

Kehinde, Oyedele Abdul Quddus, Damilare, Boyenle Ibrahim, OGUNLANA, ABDEEN TUNDE, Ayoola, Ashiru Mojeed, Emmanuel, Atanda Opeyemi, & Isaac, Adelusi Temitope. (2022). Inhibitors of α,-glucosidase and Angiotensin-converting Enzyme in the Treatment of Type 2 Diabetes and its Complications: A Review on in Silico Approach (Review Article). PHARMACEUTICAL AND BIOMEDICAL RESEARCH, 8(4), 237-258. SID. https://sid.ir/paper/1068691/en

Vancouver: Copy

Kehinde Oyedele Abdul Quddus, Damilare Boyenle Ibrahim, OGUNLANA ABDEEN TUNDE, Ayoola Ashiru Mojeed, Emmanuel Atanda Opeyemi, Isaac Adelusi Temitope. Inhibitors of α,-glucosidase and Angiotensin-converting Enzyme in the Treatment of Type 2 Diabetes and its Complications: A Review on in Silico Approach (Review Article). PHARMACEUTICAL AND BIOMEDICAL RESEARCH[Internet]. 2022;8(4):237-258. Available from: https://sid.ir/paper/1068691/en

IEEE: Copy

Oyedele Abdul Quddus Kehinde, Boyenle Ibrahim Damilare, ABDEEN TUNDE OGUNLANA, Ashiru Mojeed Ayoola, Atanda Opeyemi Emmanuel, and Adelusi Temitope Isaac, “Inhibitors of α,-glucosidase and Angiotensin-converting Enzyme in the Treatment of Type 2 Diabetes and its Complications: A Review on in Silico Approach (Review Article),” PHARMACEUTICAL AND BIOMEDICAL RESEARCH, vol. 8, no. 4, pp. 237–258, 2022, [Online]. Available: https://sid.ir/paper/1068691/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops